NCT02079506

Pharmacokinetic Drug Interaction Between Candesartan and Rosuvastatin

An Open-label, Multiple-dosing, Two-arm, One-sequence, Crossover Study to Evaluate the Safety and Pharmacokinetics After Oral Concurrent Administration of Candesartan 32 mg and Rosuvastatin 20 mg in Healthy Male Volunteers

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 40 (actual)
• Sponsor: Alvogen Korea · Industry
• Sex: Male
• Age: 20 Years – 45 Years
• Healthy volunteers: Accepted

Summary

The objective of this study is to compare pharmacokinetics after single oral administration of candesartan and rosuvastatin each separately versus coadministration of candesartan and rosuvastatin in healthy male volunteers.

Conditions

• Healthy

Interventions

Type	Name	Description
DRUG	Candesartan
DRUG	Rosuvastatin

Timeline

• Start date: 2014-02-01
• Primary completion: 2014-02-01
• Completion: 2014-02-01
• First posted: 2014-03-05
• Last updated: 2014-03-05

Locations

1 site across 1 country: South Korea